Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To determine the reproducibility of measurements of brain 5-HT2A receptors with an [18F]altanserin PET bolus/infusion approach. Further, to estimate the sample size needed to detect regional differences between two groups and, finally, to evaluate how partial volume correction affects reproducibility and the required sample size.
For assessment of the variability, six subjects were investigated with [18F]altanserin PET twice, at an interval of less than 2 weeks. The sample size required to detect a 20% difference was estimated from [18F]altanserin PET studies in 84 healthy subjects. Regions of interest were automatically delineated on co-registered MR and PET images.
In cortical brain regions with a high density of 5-HT2A receptors, the outcome parameter (binding potential, BP1) showed high reproducibility, with a median difference between the two group measurements of 6% (range 5–12%), whereas in regions with a low receptor density, BP1 reproducibility was lower, with a median difference of 17% (range 11–39%). Partial volume correction reduced the variability in the sample considerably. The sample size required to detect a 20% difference in brain regions with high receptor density is approximately 27, whereas for low receptor binding regions the required sample size is substantially higher.
This study demonstrates that [18F]altanserin PET with a bolus/infusion design has very low variability, particularly in larger brain regions with high 5-HT2A receptor density. Moreover, partial volume correction considerably reduces the sample size required to detect regional changes between groups.
- Ito, H, Nyberg, S, Halldin, C, Lundkvist, C, Farde, L (1998) PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. J Nucl Med 39: pp. 208-214
- Biver, F, Goldman, S, Luxen, A, Monclus, M, Forestini, M, Mendlewicz, J (1994) Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography. Eur J Nucl Med 21: pp. 937-946 CrossRef
- Kristiansen, H, Elfving, B, Plenge, P, Pinborg, LH, Gillings, N, Knudsen, GM (2005) Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907. Synapse 58: pp. 249-257 CrossRef
- Price, JC, Lopresti, BJ, Meltzer, CC, Smith, GS, Mason, NS, Huang, Y (2001) Analyses of [18F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans. Synapse 41: pp. 11-21 CrossRef
- Pinborg, LH, Adams, KH, Svarer, C, Holm, S, Hasselbalch, SG, Haugbol, S (2003) Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach. J Cereb Blood Flow Metab 23: pp. 985-996 CrossRef
- Smith, GS, Price, JC, Lopresti, BJ, Huang, Y, Simpson, N, Holt, D (1998) Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Synapse 30: pp. 380-392 CrossRef
- Adams, KH, Pinborg, LH, Svarer, C, Hasselbalch, SG, Holm, S, Haugbol, S (2004) A database of [18F]-altanserin binding to 5-HT2A receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 21: pp. 1105-1113 CrossRef
- DeGrado, TR, Turkington, TG, Williams, JJ, Stearns, CW, Hoffman, JM, Coleman, RE (1994) Performance characteristics of a whole-body PET scanner. J Nucl Med 35: pp. 1398-1406
- Lewellen, TK, Kohlmeyr, SG, Miyaoka, RS, Kaplan, MS, Stearns, CW, Schubert, SF (1996) Investigation of the performance of the General Electric ADVANCE positron emission tomograph in 3D mode. IEEE Trans Nucl Sci 43: pp. 2199-2206 CrossRef
- Woods, RP, Cherry, SR, Mazziotta, JC (1992) Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 16: pp. 620-633 CrossRef
- Sadzot, B, Lemaire, C, Maquet, P, Salmon, E, Plenevaux, A, Degueldre, C (1995) Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls. J Cereb Blood Flow Metab 15: pp. 787-797
- Dyck, CH, Tan, PZ, Baldwin, RM, Amici, LA, Garg, PK, Ng, CK (2000) PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin. J 41: pp. 234-241
- Lopresti, B, Holt, D, Mason, NS, Huang, Y, Ruszkiewicz, J, Perevuznik, J Characterization of the radiolabeled metabolites of [18F]altanserin: implications for kinetic modeling. In: Carson, RE, Daube-Witherspoon, ME, Herscovitch, P eds. (1998) Quantitative functional brain imaging with positron emission tomography. Academic Press, San Diego, pp. 293-298
- Willendrup P, Pinborg LH, Hasselbalch SG, Adams KH, Stahr K, Knudsen GM, et al. Assessment of the precision in co-registration of structural MR-images and PET-images with localized binding. In: Iida H, Shah NJ, Hayashi T, Watabe H. Quantification in biomedical imaging with PET and MRI. International Congress Series. 2004;1265:275–80.
- Svarer, C, Madsen, K, Hasselbalch, SG, Pinborg, LH, Haugbol, S, Frokjaer, VG (2005) MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 24: pp. 969-979 CrossRef
- Mueller-Gaertner, HW, Links, JM, Prince, JL, Bryan, RN, McVeigh, E, Leal, JP (1992) Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab 12: pp. 571-583
- Quarantelli, M, Berkouk, K, Prinster, A, Landeau, B, Svarer, C, Balkay, L (2004) Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med 45: pp. 192-201
- Kapur, S, Jones, C, DaSilva, J, Wilson, A, Houle, S (1997) Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging. Nucl Med Commun 18: pp. 395-399 CrossRef
- Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach
European Journal of Nuclear Medicine and Molecular Imaging
Volume 34, Issue 6 , pp 910-915
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Sample size estimation
- Serotonin receptor
- Partial volume correction
- Industry Sectors
- Author Affiliations
- 1. Neurobiology Research Unit, Centre for Integrated Molecular Brain Imaging, Copenhagen University Hospital, 9 Blegdamsvej, 2100, Copenhagen, Denmark
- 2. PET and Cyclotron Unit, Copenhagen University Hospital, Copenhagen, Denmark
- 3. Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital, Copenhagen, Denmark